Colistin monotherapy versus colistin/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: A randomised controlled trial

Leite, 2016, Antimicrobial combinations against pan-resistant Acinetobacter baumannii isolates with different resistance mechanisms, PLoS One, 11, e0151270, 10.1371/journal.pone.0151270

Oliva, 2017, Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia, New Microbiol, 40, 205

Lertsrisatit, 2017, In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital, Infect Drug Resist, 10, 437, 10.2147/IDR.S148185

Bae, 2016, In vitro synergistic activity of antimicrobial agents in combination against clinical isolates of colistin-resistant Acinetobacter baumannii, Antimicrob Agents Chemother, 60, 6774, 10.1128/AAC.00839-16

Hong, 2016, In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates, Diagn Microbiol Infect Dis, 86, 184, 10.1016/j.diagmicrobio.2016.07.017

Lee, 2016, In vitro synergistic effects of antimicrobial combinations on extensively drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates, Ann Lab Med, 36, 138, 10.3343/alm.2016.36.2.138

Bremmer, 2016, Correlation of checkerboard synergy testing with time–kill analysis and clinical outcomes of extensively drug-resistant Acinetobacter baumannii respiratory infections, Antimicrob Agents Chemother, 60, 6892, 10.1128/AAC.00981-16

Karlowsky, 2003, Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001, Antimicrob Agents Chemother, 47, 1681, 10.1128/AAC.47.5.1681-1688.2003

Edwards, 1994, Harmonisation in pharmacovigilance, Drug Saf, 10, 93, 10.2165/00002018-199410020-00001

Meyboom, 1997, Causal or casual? The role of causality assessment in pharmacovigilance, Drug Saf, 17, 374, 10.2165/00002018-199717060-00004

Manchanda, 2010, Multidrug resistant Acinetobacter, J Glob Infect Dis, 2, 291, 10.4103/0974-777X.68538

Li, 2006, Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii, Antimicrob Agents Chemother, 50, 2946, 10.1128/AAC.00103-06

Rodriguez, 2009, Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin, Diagn Microbiol Infect Dis, 65, 188, 10.1016/j.diagmicrobio.2009.05.019

Qureshi, 2015, Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance, Clin Infect Dis, 60, 1295, 10.1093/cid/civ048

Kim, 2015, In vivo selection of pan-drug resistant Acinetobacter baumannii during antibiotic treatment, Yonsei Med J, 56, 928, 10.3349/ymj.2015.56.4.928

Lee, 2017, Transition of colistin dependence into colistin resistance in Acinetobacter baumannii, Sci Rep, 7, 14216, 10.1038/s41598-017-14609-0

Durante-Mangoni, 2013, Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial, Clin Infect Dis, 57, 349, 10.1093/cid/cit253

Nordqvist, 2016, Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii, Eur J Clin Microbiol Infect Dis, 35, 1845, 10.1007/s10096-016-2736-3

Maragakis, 2008, Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options, Clin Infect Dis, 46, 1254, 10.1086/529198

Gordon, 2010, Potent synergy and sustained bactericidal activity of a vancomycin–colistin combination versus multidrug-resistant strains of Acinetobacter baumannii, Antimicrob Agents Chemother, 54, 5316, 10.1128/AAC.00922-10

Nastro, 2014, Activity of the colistin–rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria, J Chemother, 6

Mackay, 2000, Comparison of methods for assessing synergic antibiotic interactions, Int J Antimicrob Agents, 15, 125, 10.1016/S0924-8579(00)00149-7

Pankey, 2013, Comparison of 3 Etest® methods and time–kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species, Diagn Microbiol Infect Dis, 77, 220, 10.1016/j.diagmicrobio.2013.07.006